Literature DB >> 19645581

Stability of canine pancreatic lipase immunoreactivity concentration in serum samples and effects of long-term administration of prednisone to dogs on serum canine pancreatic lipase immunoreactivity concentrations.

Jörg M Steiner1, Sheila R Teague, George E Lees, Michael D Willard, David A Williams, Craig G Ruaux.   

Abstract

OBJECTIVE: To evaluate stability of canine pancreatic lipase immunoreactivity (cPLI) in serum samples and to determine the effect of long-term administration of prednisone on serum cPLI concentrations. SAMPLE POPULATION: 8 canine serum samples for the stability evaluation and serum samples obtained from 6 healthy young adult heterozygous (carrier) dogs with X-linked hereditary nephritis for determining the effect of prednisone administration. PROCEDURES: To evaluate stability of serum cPLI concentration, an aliquot of each serum sample was stored at each of 4 temperatures between -80 degrees and 24 degrees C; samples were analyzed on days 0, 3, 7, 14, and 21. To determine the effect of long-term prednisone administration, pretreatment serum samples were obtained (days 0 and 14) and prednisone was administered (2.2 mg/kg, q 24 h, PO) on days 15 through 42, with serum samples obtained on days 28 and 42. Additional serum samples were obtained on days 56 and 70.
RESULTS: Mean serum cPLI concentrations did not change significantly from day 0 to day 21 regardless of storage temperature. Serum cPLI concentrations in dogs after prednisone administration were within the reference range for all dogs at all time points, and results of repeated-measures ANOVA revealed that serum cPLI concentrations did not change significantly over time. CONCLUSIONS AND CLINICAL RELEVANCE: Serum cPLI concentrations measured in canine serum samples stored at room temperature, in a refrigerator, or in a freezer at -20 degrees or -80 degrees C were stable for at least 21 days. Also, long-term prednisone administration to dogs did not significantly affect serum cPLI concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19645581     DOI: 10.2460/ajvr.70.8.1001

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  13 in total

1.  Asparaginase-associated pancreatitis in a dog.

Authors:  Stephanie E Schleis; Scott A Rizzo; Jeffery C Phillips; Amy K LeBlanc
Journal:  Can Vet J       Date:  2011-09       Impact factor: 1.008

2.  Effects of immunosuppressive prednisolone therapy on pancreatic tissue and concentration of canine pancreatic lipase immunoreactivity in healthy dogs.

Authors:  Hiroshi Ohta; Kazuki Kojima; Nozomu Yokoyama; Noboru Sasaki; Yumiko Kagawa; Kiwamu Hanazono; Tomohito Ishizuka; Keitaro Morishita; Kensuke Nakamura; Satoshi Takagi; Mitsuyoshi Takiguchi
Journal:  Can J Vet Res       Date:  2018-10       Impact factor: 1.310

3.  Canine pancreatic-specific lipase concentrations in clinically healthy dogs and dogs with naturally occurring hyperadrenocorticism.

Authors:  D I Mawby; J C Whittemore; K A Fecteau
Journal:  J Vet Intern Med       Date:  2014-06-05       Impact factor: 3.333

Review 4.  Laboratory tests for diagnosis of gastrointestinal and pancreatic diseases.

Authors:  Olivier Dossin
Journal:  Top Companion Anim Med       Date:  2011-05

5.  Hyperlipasemia in critically ill dogs with and without acute pancreatitis: Prevalence, underlying diseases, predictors, and outcome.

Authors:  Julia K Prümmer; Judith Howard; Lisa M Grandt; Rafael Obrador de Aguilar; Felix Meneses; Laureen M Peters
Journal:  J Vet Intern Med       Date:  2020-09-18       Impact factor: 3.333

6.  ACVIM consensus statement on pancreatitis in cats.

Authors:  Marnin A Forman; Joerg M Steiner; P Jane Armstrong; Melinda S Camus; Lorrie Gaschen; Steve L Hill; Caroline S Mansfield; Katja Steiger
Journal:  J Vet Intern Med       Date:  2021-02-15       Impact factor: 3.333

Review 7.  Advances in the diagnosis of acute pancreatitis in dogs.

Authors:  Harry Cridge; David C Twedt; Angela J Marolf; Leslie C Sharkey; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2021-11-09       Impact factor: 3.333

8.  Increased canine pancreatic lipase immunoreactivity (cPLI) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in dogs with evidence of portal hypertension and normal pancreatic histology: a pilot study.

Authors:  Gonçalo Serrano; Dominique Paepe; Tim Williams; Penny Watson
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

9.  Evaluation of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) and 1,2-diglyceride lipase assays in dogs with naturally occurring hypercortisolism.

Authors:  Guido Linari; Francesco Dondi; Sofia Segatore; Kateryna Vasylyeva; Nikolina Linta; Marco Pietra; Rodolfo O Leal; Federico Fracassi
Journal:  J Vet Diagn Invest       Date:  2021-06-02       Impact factor: 1.569

10.  Effect of prednisolone therapy on serum levels of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester lipase in dogs.

Authors:  Beatriz Mendoza; Maria Joana Dias; Telmo Nunes; Maria Alexandra Basso; Juan Hernandez; Rodolfo Oliveira Leal
Journal:  J Vet Intern Med       Date:  2020-11-04       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.